The BlandM-1 Antibody (PAC035070) is a polyclonal antibody designed for research involving the BlandM-1 protein, a cell surface molecule associated with immune regulation. This antibody, raised in rabbits, is highly reactive with human samples and has been validated for use in various applications, including Western blotting. By binding specifically to the BlandM-1 protein, this antibody enables the detection and analysis of BlandM-1 in different cell types, making it an ideal tool for studies in immunology and cancer research.
BlandM-1, also known as an immune modulator, plays a crucial role in regulating immune responses by inhibiting certain immune functions. Its involvement in immune modulation makes it a promising target for research on diseases such as cancer, autoimmune disorders, and chronic inflammatory conditions. Understanding the role of BlandM-1 is essential for developing new therapies that target or alter immune responses in these disease contexts.
Antibody Name:
blaNDM-1 Antibody (PACO35070)
Antibody SKU:
PACO35070
Size:
50ug
Host Species:
Rabbit
Tested Applications:
ELISA
Recommended Dilutions:
Species Reactivity:
Klebsiella pneumoniae
Immunogen:
Recombinant Klebsiella pneumoniae Metallo-beta-lactamase type 2 protein (29-270AA)
Confers resistance to many beta-lactam antibiotics, including some carbapenems. Does not confer resistance to the polymixin colistin or the fluoroquinolone ciprofloxacin.
Synonyms:
Metallo-beta-lactamase type 2 (EC 3.5.2.6) (B2 metallo-beta-lactamase) (Beta-lactamase type II) (Metallo-beta-lactamase NDM-1) (Metallo-beta-lactamase type II) (New Delhi metallo-beta-lactamase-1) (NDM-1), blaNDM-1
UniProt Protein Function:
Confers resistance to the different beta-lactams antibiotics (penicillin, cephalosporin and carbapenem) via the hydrolysis of the beta-lactam ring. Does not confer resistance to the polymixin colistin or the fluoroquinolone ciprofloxacin.
